Elanco Animal Health Inc. ELAN Product Sales — Accounts Receivable

Similar metrics at other companies

BMRNProduct One — Accounts Receivable Net Current

$26.01M—

ESIAnimal Health — Revenue

$6.7M-18.3%

NWSAFinancial Services — Accounts Receivable, Net

$121M—

DEProduction And Precision Agriculture — Accounts Receivable Net

$1.67B+9.2%

DESmall Agriculture And Turf — Accounts Receivable Net

$1.97B+18.7%

FLSEngineered Product Division — Accounts Receivable Net Current

-$9.5M—

Questions, answered.

What is Elanco Animal Health Inc.'s product sales — accounts receivable?

Elanco Animal Health Inc. (ELAN) reported product sales — accounts receivable of $117M in Q1 2026.

How has Elanco Animal Health Inc.'s product sales — accounts receivable changed year-over-year?

Elanco Animal Health Inc.'s product sales — accounts receivable decreased by 0.8% year-over-year, from $118M to $117M.

What is the long-term trend for Elanco Animal Health Inc.'s product sales — accounts receivable?

Over 4 years (2021 to 2025), Elanco Animal Health Inc.'s product sales — accounts receivable has grown at a 8.7% compound annual growth rate (CAGR), from $329M to $460M.

What does product sales — accounts receivable mean?

The net amount of money owed to the company by customers for animal health products sold but not yet paid for.

How do you interpret product sales — accounts receivable?

An increase relative to sales may signal deteriorating customer credit quality or aggressive revenue recognition, while a decrease suggests efficient cash collection cycles.

How does product sales — accounts receivable compare across companies?

Peers in the animal health and pharmaceutical sectors typically maintain similar metrics, often benchmarked against Days Sales Outstanding (DSO) to normalize for company size.